First Randomized Trial of Azacitidine w/ Durvalumab for the Front-Line Treatment of Older Pts with AML and MDS: Data Presented at ASH 2019
By
Yale Cancer Center
FEATURING
Amer Zeidan
By
Yale Cancer Center
FEATURING
Amer Zeidan
Login to view comments.
Click here to Login